Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?
Authors
Keywords
Immune-checkpoint inhibitors, Antibody–drug conjugate, Immunogenic cell death, Immuno-onocology, Combination treatment
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 102, Issue -, Pages 1-6
Publisher
Elsevier BV
Online
2015-12-17
DOI
10.1016/j.bcp.2015.12.008

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.